Evidence map›Paper›PMID 41036466›Full record

ArticleMolecular therapy. Nucleic acids2025

Dynamic regulation of NeuroD1 expression level by a novel viral construct during astrocyte-to-neuron reprogramming.

Natalie Mseis-Jackson, Mei Jiang, Mehek Sharma, Arya Ranchod, Christine Williams, Xuanyu Chen, Hedong Li

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Natalie Mseis-JacksonDepartment of Neuroscience & Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Mei JiangDepartment of Neuroscience & Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Mehek SharmaMedical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Arya RanchodDepartment of Biological Sciences, College of Science & Mathematics, Augusta University, Augusta, GA 30912, USA.
Christine WilliamsDepartment of Chemistry & Physics, College of Science & Mathematics, Augusta University, Augusta, GA 30912, USA.
Xuanyu ChenDepartment of Neuroscience & Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Hedong LiDepartment of Neuroscience & Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.

Funding

MicroRNA Function During Neuronal Reprogramming in Treating Spinal Cord InjuryR01NS117918 · NINDS · AUGUSTA UNIVERSITY · PI LI, HEDONG · 2020 to 2024
$1.8M
In Vivo Reprogramming Reactive Astrocytes into Functional Neuorons by MicroRNA-124 in the Injured Spinal CordR21NS104394 · NINDS · PENNSYLVANIA STATE UNIVERSITY, THE · PI LI, HEDONG · 2018 to 2019
$440k
Manipulating NeuroD1 expression by MicroRNAs to Optimize Neuronal Conversion for Spinal Cord Injury RepairR21NS119732 · NINDS · AUGUSTA UNIVERSITY · PI LI, HEDONG · 2021 to 2022
$424k
NINDS NIH HHS R01 NS117918NINDS NIH HHS R21 NS104394NINDS NIH HHS R21 NS119732
6 · The paper itself

Abstract

Astrocyte-to-neuron reprogramming presents a viable approach for regenerative medicine. The reprogramming factor NeuroD1 has demonstrated the capability of neuronal reprogramming with high efficiency and yet primarily glutamatergic neuronal subtype. However, diversified neuronal subtypes are needed to establish appropriate neuronal connectivity in disease/injury conditions. We reason that continuously high level of NeuroD1 expression forces the reprogrammed neurons into glutamatergic subtype and that reducing NeuroD1 level after reprogramming may allow the generation of neurons with diversified subtypes. For this purpose, we engineered a novel viral expression vector by which NeuroD1 expression can be dynamically regulated during the reprogramming process. Specifically, the target site of a neuron-specific microRNA (miR-124) is incorporated in the expression system. Therefore, this novel construct would still achieve a high NeuroD1 expression level in astrocytes for reprogramming to occur and yet reduce its level in the reprogrammed neurons by suppression of endogenous miR-124. In this study, we demonstrated that this construct elicits a dynamic gene expression pattern with much reduced level of NeuroD1 at later stages of neuronal reprogramming. We also showed that this construct still retains relatively high reprogramming efficiency and can generate mature neurons with an enhanced GABAergic neuronal phenotype.

Indexed as

astrocytemicroRNAmiR-124MT: Oligonucleotides: Therapies and ApplicationsNeuroD1neuronal reprogramming

Identifiers

PMID41036466
PMCPMC12483663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.